1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66EFA3433558F9DBA652582D6002C0C18
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/connecting-pharma-digital-patient-engagement-strategies-global-emerging-developed-markets?opendocument
18
19opendocument
2054.157.61.68
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services Marketing Management Patient Advocacy

Connecting Pharma to Patients with Digital Patient Engagement Strategies in Global, Emerging, and Developed Markets

ID: PSM-354


Features:

12 Info Graphics

67 Data Graphics

1130+ Metrics

10 Narratives


Pages: 97


Published: 2018


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Technology advancement in the healthcare landscape has paved the way for a holistic approach to patient engagement, with leading pharma and biotech organizations moving rapidly toward high levels of digital patient engagement across the global market.

Best Practices, LLC undertook this
benchmarking research to highlight the winning strategies, effective practices, and potential stumbling blocks encountered as companies shift toward digital patient engagement in global, emerging and developed markets.

This report provides digital patient engagement benchmarks around the tactics, tools and technologies employed for successful engagement; key staffing drivers; investment trends; structure and reporting models; processes and use of vendors; depth and scope of engagement; performance effectiveness; and critical lessons learned.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Manufacturing; Consumer Products; Medical Device; Chemical; Biopharmaceutical; Research; Clinical Research; Laboratories


Companies Profiled:
Abbott; AbbVie; Alexion Pharmaceuticals; Allergan; Astellas; AstraZeneca; Bayer; B. Braun; Cadila Pharmaceuticals; Cordis; Ferring Pharmaceuticals; Fidia; Genentech; Horizon Pharma; Incyte; Ipsen; Janssen; LEO Pharma; Medtronic; Meyer; MSD; Novartis; Novo Nordisk; Parexel; Pfizer; Pharmacyclics; Reata Pharmaceuticals; Roche; Sanofi; Sunovion; Synexus; Teva Pharmaceutical Industries Ltd; UCB Pharma; Vifor Pharma


Study Snapshot

Best Practices, LLC engaged 54 industry professionals involved in digital patient engagement programs at 34 leading pharmaceutical, biotechnology and medical device companies through a benchmarking survey instrument. Report insights are presented into three segments: Global Market Segment (19 respondents), Developed Market Segment (20 respondents) and Emerging Market Segment (15 respondents).

Key topics covered in this report include:
  • Drivers of program creation
  • Frequency of outreach to patients
  • Spending on digital patient engagement tools utilized for patient outreach
  • Measuring the effectiveness of programs


Key Findings

Sample key insights uncovered from this report are noted below. Detailed findings are available in the full report.
  • Emerging markets spend a smaller portion of their patient engagement budget (15%) on digital activities compared to Global (33%) and Developed markets (41%).
  • Highly mature companies have different priorities regarding activities they should be implementing. Highly mature companies rate market research, co-pay assistance, and social influencers as “Very Effective” for increasing engagement more often than their less mature counterparts.
Table of Contents

I
Executive Summarypp. 4-6
Summary of findingsp. 5
Detailed summaryp. 6
II
Participant Profilepp. 7-15
Segmentationp. 8
Response geography and perspectivespp. 9-15
III
Key Findingspp. 16-31
Operational systems wheelp. 17
Global vs. Developed vs. Emerging marketspp. 18-31
IV
BRICS Insightspp. 32-35
V
Technology and Tools for Successful Engagement Programspp. 36-43
Effective toolspp. 37-41
Access to health recordspp. 42-43
VI
Staffing for Patient Engagementpp. 44-49
VII
Investment in Digital Engagementpp. 50-57
Spending proportionspp. 51-55
Groups investing in digital patient engagementpp. 56-57
VIII
Structure of Patient Engagement Groupspp. 58-63
Outreach to HCPs vs. patientspp. 59-60
Reporting structurepp. 61-63
IX
Processes and Vendors Usedpp. 64-69
Working with legal and external groupspp. 65-66
Top vendor insightspp. 67-69
X
Service Levels: Engagement Scope and Depth Deliveredpp. 70-75
XI
Aligning Marketing with the Patient Journeypp. 76-78
XII
Performance Metricspp. 79-87
XIII
Lessons Learned from Qualitative Insightspp. 88-91
XIV
Demographic Profilespp. 92-96
XV
About Best Practices, LLCp. 97

    List of Charts & Exhibits

    I. Key Findings
    • Twelve dimensions through which to understand operational systems

    II. Global vs. Developed vs. Emerging Markets
    • Factors influencing the level of staffing within Digital Patient Engagement groups - Emerging markets vs. Developed markets
    • Percentage of external engagement budget for patient engagement and HCP outreach devoted to digital initiatives in global, emerging and developed markets
    • Percentage of external engagement budget for patient engagement and HCP outreach to be devoted to digital initiatives in global, emerging and developed markets in the next three years
    • Percentage of budget devoted to digital patient engagement activities and programs
    • Involvement level of targeted patients in the digital patient engagement program
    • Top performing patient-focused marketing activities in global, emerging and developed markets
    • Outreach frequency to patients and HCPs in global, emerging and developed markets through external engagement programs
    • Patient health record access in global, emerging and developed markets
    • Digital tactics or technologies employed for patient engagement across global, emerging and developed markets
    • Countries within developed and emerging markets where benchmark partners have had the greatest impact with their digital patient engagement programs
    • Effectiveness of patient engagement activities across global, emerging and developed markets
    • Level of satisfaction among benchmark partners with the overall awareness achieved through HCP and patient outreach programs in each of the markets
    • Effectiveness of patient feedback tools across all markets
    • Effective metrics for evaluating the success of digital patient engagement programs

    III. BRICS Insights
    • Digital patient engagement tactics and tools employed in Brazil, Russia and India
    • Digital patient engagement tactics and tools employed in China and South Africa
    • Percentage of budget devoted to digital HCP outreach and digital patient engagement in each of the BRICS countries

    IV. Technology and Tools for Successful Engagement Programs
    • Digital tactics or technologies employed in digital patient engagement programs across all markets
    • Effectiveness of patient market research and digital assistants through tech partnerships in digital patient engagement programs
    • Digital components utilized as part of the digital patient engagement program across all countries
    • Effectiveness of patient engagement activities across all countries
    • Effective patient feedback tools for segmenting patients to receive engagement messages aligned with different phases of their journey
    • Patient engagement group’s involvement with patient health records in global, emerging and developed markets
    • Patient engagement group’s involvement with patient health records in global, emerging and developed markets in the next three years

    V. Staffing for Patient Engagement
    • Factors influencing the level of staffing within digital patient engagement groups in global, emerging and developed markets
    • FTEs allocated to digital patient engagement programs in each reporting market
    • Level of outsourcing within the digital patient engagement group across all markets
    • Digital patient engagement staffing drivers across the benchmark class

    VI. Investment in Digital Engagement
    • Proportion of external engagement budget devoted to patient engagement across all markets and proportion of budget to be allotted in the next three years
    • Proportion of external engagement budget devoted to digital patient engagement across all markets and proportion of budget to be allotted in the next three years
    • Proportion of external engagement budget devoted to HCP outreach across all markets and proportion of budget to be allotted in the next three years
    • Proportion of external engagement budget devoted to digital HCP outreach across all markets and proportion of budget to be allotted in the next three years
    • Percentage of total patient marketing spend allocated to selected programs and activities
    • Budget source for digital patient engagement activities across global, emerging and developed markets
    • Budget source for digital patient engagement activities across the benchmark class

    VII. Structure of Patient Engagement Groups
    • Frequency of outreach to HCPs and patients through external engagement programs – Total benchmark class
    • Frequency of outreach to HCPs and patients through external engagement programs in emerging markets
    • Reporting structure for digital patient engagement programs across the benchmark class
    • Reporting structure for digital patient engagement programs across emerging and developed markets
    • Effective knowledge transfer channels for digital patient engagement programs

    VIII. Processes and Vendors Used
    • Involvement level of the legal and compliance departments in listed patient engagement activities
    • Importance of listed patient advocacy group activities and support services when building and maintaining digital patient engagement programs
    • Top vendors for developing and implementing digital patient engagement programs
    • Valuable lessons learnt while working with a vendor in developing or implementing a digital patient engagement program

    IX. Service Levels: Engagement Scope and Depth Delivered
    • Satisfaction level among participants with the overall awareness achieved through their patient and HCP outreach program
    • Importance of patient advocacy group activities and support services when building and maintaining digital patient engagement programs
    • Activities and programs included in the total current digital patient engagement spend – Total benchmark class
    • Activities and programs included in the total current digital patient engagement spend – Global, emerging and developed markets
    • Benchmark partners’ perception regarding their external engagement efforts

    X. Aligning Marketing with the Patient Journey
    • Digital patient engagement investment trends – Total benchmark class
    • Digital patient engagement investment trends – Global, emerging and developed markets

    XI. Performance Metrics
    • Metrics used to track the success of patient-focused digital marketing activities – Global, emerging and developed markets
    • Satisfaction levels with patient and HCP outreach awareness efforts
    • Satisfaction levels with the engagement driven through patient engagement programs
      Success of digital patient-focused marketing activities and programs
    • Factors influencing a company’s digital patient engagement program development strategy
    • Effectiveness of patient engagement activities
    • Effectiveness of patient feedback tools

    XII. Lessons Learned from Qualitative Insights
    • Countries / regions having the greatest impact with digital patient engagement programs
    • Most critical lessons learned regarding digital patient engagement programs in emerging markets